

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

Workers handle Covid-19 vaccines at a distribution center in Chandigarh, India on May 4, 2021. (Photo: Ravi Kumar/Hindustan Times via Getty Images)
As the United States on Wednesday broke with other wealthy nations to support waiving intellectual property protections for Covid-19 vaccines, global health leaders applauded President Joe Biden's administration, while healthcare advocates shifted the focus of their pressure to other countries whose leaders are either undecided or opposed to the move.
"If the U.S. truly wants to end this pandemic, it must also share its surplus vaccines doses with COVAXnow and fill the access gap until additional manufactures are able to scale up production."
--Avril Benoit, MSF
World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus, a vocal advocate of the waiver, led the worldwide praise of the American policy shift.
"This is a monumental moment in the fight against Covid-19," Tedros said in a statement. "The commitment by... Biden and Ambassador Katherine Tai, the U.S. trade representative, to support the waiver of IP protections on vaccines is a powerful example of American leadership to address global health challenges."
"I commend the United States on its historic decision for vaccine equity and prioritizing the well-being of all people everywhere at a critical time," he added. "Now let's all move together swiftly, in solidarity, building on the ingenuity and commitment of scientists who produced lifesaving Covid-19 vaccines."
Avril Benoit, executive director of the U.S. division of the international medical charity Medecins Sans Frontieres (MSF, or Doctors Without Borders), also welcomed news of the Biden administration's decision--while pushing the United States to do more.
"MSF applauds the U.S. government's bold decision to support the waiving of intellectual property on Covid-19 vaccines during this time of unprecedented global need," Benoit said in a statement. "It is crucial that this waiver not just apply to preventative vaccines, but it should also cover other medical tools for Covid-19, including treatments for people who fall ill and diagnostics to help curb the spread, as originally proposed seven months ago."
"If the U.S. truly wants to end this pandemic, it must also share its surplus vaccines doses with COVAX now and fill the access gap until additional manufactures are able to scale up production," Benoit added. "The U.S. must also demand that pharma companies that received significant amounts of U.S. taxpayer funding to create these vaccines share the technology and know-how with other capable manufacturers to protect more people worldwide."
Benoit called on other wealthy members of the World Trade Organization to follow the U.S. lead.
"Countries that continue to oppose the WTO waiver--such as European Union countries, the United Kingdom, Switzerland, Canada, Australia, Norway, Japan, and Brazil--must now take action, too and decide to put people's health before pharmaceutical profits and waive IP on all Covid-19 medical tools, including vaccines," she wrote.
Healthcare advocates turned their attention those countries after the Biden administration's announcement, with many eyes on the U.S.' neighbor to the north. Some of the admonition of Ottawa was deadly serious:
Canada needs to immediately drop its opposition to a WTO patent waiver on vaccines. Now the US has reversed position, Canada has no reason to hold out. There's no big domestic industry to protect, and if the US can do it......
-- Lauren Dobson-Hughes (@ldobsonhughes) May 5, 2021
Other criticism oozed derision and disdain:
Meanwhile, the world registered more than 800,000 new Covid-19 cases--more than 300,000 of them in India--and nearly 14,000 new deaths on Tuesday, according to the Johns Hopkins Coronavirus Resource Center.
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
As the United States on Wednesday broke with other wealthy nations to support waiving intellectual property protections for Covid-19 vaccines, global health leaders applauded President Joe Biden's administration, while healthcare advocates shifted the focus of their pressure to other countries whose leaders are either undecided or opposed to the move.
"If the U.S. truly wants to end this pandemic, it must also share its surplus vaccines doses with COVAXnow and fill the access gap until additional manufactures are able to scale up production."
--Avril Benoit, MSF
World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus, a vocal advocate of the waiver, led the worldwide praise of the American policy shift.
"This is a monumental moment in the fight against Covid-19," Tedros said in a statement. "The commitment by... Biden and Ambassador Katherine Tai, the U.S. trade representative, to support the waiver of IP protections on vaccines is a powerful example of American leadership to address global health challenges."
"I commend the United States on its historic decision for vaccine equity and prioritizing the well-being of all people everywhere at a critical time," he added. "Now let's all move together swiftly, in solidarity, building on the ingenuity and commitment of scientists who produced lifesaving Covid-19 vaccines."
Avril Benoit, executive director of the U.S. division of the international medical charity Medecins Sans Frontieres (MSF, or Doctors Without Borders), also welcomed news of the Biden administration's decision--while pushing the United States to do more.
"MSF applauds the U.S. government's bold decision to support the waiving of intellectual property on Covid-19 vaccines during this time of unprecedented global need," Benoit said in a statement. "It is crucial that this waiver not just apply to preventative vaccines, but it should also cover other medical tools for Covid-19, including treatments for people who fall ill and diagnostics to help curb the spread, as originally proposed seven months ago."
"If the U.S. truly wants to end this pandemic, it must also share its surplus vaccines doses with COVAX now and fill the access gap until additional manufactures are able to scale up production," Benoit added. "The U.S. must also demand that pharma companies that received significant amounts of U.S. taxpayer funding to create these vaccines share the technology and know-how with other capable manufacturers to protect more people worldwide."
Benoit called on other wealthy members of the World Trade Organization to follow the U.S. lead.
"Countries that continue to oppose the WTO waiver--such as European Union countries, the United Kingdom, Switzerland, Canada, Australia, Norway, Japan, and Brazil--must now take action, too and decide to put people's health before pharmaceutical profits and waive IP on all Covid-19 medical tools, including vaccines," she wrote.
Healthcare advocates turned their attention those countries after the Biden administration's announcement, with many eyes on the U.S.' neighbor to the north. Some of the admonition of Ottawa was deadly serious:
Canada needs to immediately drop its opposition to a WTO patent waiver on vaccines. Now the US has reversed position, Canada has no reason to hold out. There's no big domestic industry to protect, and if the US can do it......
-- Lauren Dobson-Hughes (@ldobsonhughes) May 5, 2021
Other criticism oozed derision and disdain:
Meanwhile, the world registered more than 800,000 new Covid-19 cases--more than 300,000 of them in India--and nearly 14,000 new deaths on Tuesday, according to the Johns Hopkins Coronavirus Resource Center.
As the United States on Wednesday broke with other wealthy nations to support waiving intellectual property protections for Covid-19 vaccines, global health leaders applauded President Joe Biden's administration, while healthcare advocates shifted the focus of their pressure to other countries whose leaders are either undecided or opposed to the move.
"If the U.S. truly wants to end this pandemic, it must also share its surplus vaccines doses with COVAXnow and fill the access gap until additional manufactures are able to scale up production."
--Avril Benoit, MSF
World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus, a vocal advocate of the waiver, led the worldwide praise of the American policy shift.
"This is a monumental moment in the fight against Covid-19," Tedros said in a statement. "The commitment by... Biden and Ambassador Katherine Tai, the U.S. trade representative, to support the waiver of IP protections on vaccines is a powerful example of American leadership to address global health challenges."
"I commend the United States on its historic decision for vaccine equity and prioritizing the well-being of all people everywhere at a critical time," he added. "Now let's all move together swiftly, in solidarity, building on the ingenuity and commitment of scientists who produced lifesaving Covid-19 vaccines."
Avril Benoit, executive director of the U.S. division of the international medical charity Medecins Sans Frontieres (MSF, or Doctors Without Borders), also welcomed news of the Biden administration's decision--while pushing the United States to do more.
"MSF applauds the U.S. government's bold decision to support the waiving of intellectual property on Covid-19 vaccines during this time of unprecedented global need," Benoit said in a statement. "It is crucial that this waiver not just apply to preventative vaccines, but it should also cover other medical tools for Covid-19, including treatments for people who fall ill and diagnostics to help curb the spread, as originally proposed seven months ago."
"If the U.S. truly wants to end this pandemic, it must also share its surplus vaccines doses with COVAX now and fill the access gap until additional manufactures are able to scale up production," Benoit added. "The U.S. must also demand that pharma companies that received significant amounts of U.S. taxpayer funding to create these vaccines share the technology and know-how with other capable manufacturers to protect more people worldwide."
Benoit called on other wealthy members of the World Trade Organization to follow the U.S. lead.
"Countries that continue to oppose the WTO waiver--such as European Union countries, the United Kingdom, Switzerland, Canada, Australia, Norway, Japan, and Brazil--must now take action, too and decide to put people's health before pharmaceutical profits and waive IP on all Covid-19 medical tools, including vaccines," she wrote.
Healthcare advocates turned their attention those countries after the Biden administration's announcement, with many eyes on the U.S.' neighbor to the north. Some of the admonition of Ottawa was deadly serious:
Canada needs to immediately drop its opposition to a WTO patent waiver on vaccines. Now the US has reversed position, Canada has no reason to hold out. There's no big domestic industry to protect, and if the US can do it......
-- Lauren Dobson-Hughes (@ldobsonhughes) May 5, 2021
Other criticism oozed derision and disdain:
Meanwhile, the world registered more than 800,000 new Covid-19 cases--more than 300,000 of them in India--and nearly 14,000 new deaths on Tuesday, according to the Johns Hopkins Coronavirus Resource Center.